Synchrony Financial
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $SYF in the last 30 days.
See all $SYF insider activity →Weave (WEAV) integrated CareCredit financing from Synchrony (SYF) into its platform, allowing healthcare practices to view patient credit status and initiate payments. A survey found 43% of Weave customers would use the service exclusively. The feature aims to streamline payment discussions and processes.
Analysts upgraded Generac (GNRC) to Buy with targets of $280 (KeyBanc) and $303 (Piper Sandler), citing Amazon's $8B deal and data-center growth. Centrus Energy (LEU) initiated at Buy with a $167 target by Guggenheim. American Express (AXP) initiated at Buy with a $380 target, highlighting its fee-based model. Synchrony (SYF) and Capital One (COF) initiated at Hold with $81 and $219 targets, respectively.
American Express (AXP) reported Q2 revenue of $18.55B, missing estimates by 5.8%, and its stock fell 10.7%. Mastercard (MA) reported $9.28B in revenue, beating estimates, and its stock rose 1.2%. Capital One (COF) reported $15.83B in revenue, meeting expectations, but its stock dropped 5%. The market has shifted focus from AI to geopolitics and back to fundamentals.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning SYF (Synchrony Financial). Coverage has skewed bullish: 2 bullish, 2 neutral, and 0 bearish.
Positive impact as CareCredit exposure expands through Weave’s large user base, potentially driving higher loan utilization.
Neutral stance suggests limited near‑term move.
No fresh catalyst; neutral outlook.
Target price increase suggests bullish outlook.
Potential downward pressure as analysts reduce valuation expectations.
AlphAI scores every news story that mentions SYF with an AI model for sentiment and relevance, and aggregates insider trades from Synchrony Financial's SEC EDGAR Form 4 filings. Figures refresh continuously.
Weave (WEAV) integrated CareCredit financing from Synchrony (SYF) into its platform, allowing healthcare practices to view patient credit status and initiate payments. A survey found 43% of Weave customers would use the service exclusively. The feature aims to streamline payment discussions and processes.
1 min readAnalysts upgraded Generac (GNRC) to Buy with targets of $280 (KeyBanc) and $303 (Piper Sandler), citing Amazon's $8B deal and data-center growth. Centrus Energy (LEU) initiated at Buy with a $167 target by Guggenheim. American Express (AXP) initiated at Buy with a $380 target, highlighting its fee-based model. Synchrony (SYF) and Capital One (COF) initiated at Hold with $81 and $219 targets, respectively.
2 min readAmerican Express (AXP) reported Q2 revenue of $18.55B, missing estimates by 5.8%, and its stock fell 10.7%. Mastercard (MA) reported $9.28B in revenue, beating estimates, and its stock rose 1.2%. Capital One (COF) reported $15.83B in revenue, meeting expectations, but its stock dropped 5%. The market has shifted focus from AI to geopolitics and back to fundamentals.
2 min readArgus raised its target price for Synchrony Financial (SYF) to $82.00. SYF is the largest U.S. provider of private-label credit cards by receivables and purchasing volume, originating from GE Capital's retail financing business.
1 min readTD Cowen maintained a 'Buy' rating for Synchrony Financial (SYF) but lowered its price target to $86.00 from $90.00. The stock is currently trading at $72.27, which is 8.6% above its GF Value™ of $66.56. Synchrony Financial has a GF Score™ of 88/100, indicating strong performance, but insider activity shows significant selling.
1 min readTD Cowen lowered its price target for Synchrony Financial from $90 to $86 while maintaining a buy rating. The stock is currently trading at $72.74, up 1.20% on the day and down 13.17% over the past year. UBS also recently adjusted its target to $81 from $87, keeping a neutral rating.
1 min readUBS maintained a Neutral rating on Synchrony Financial (SYF) but lowered its price target to $81.00 from $87.00. GuruFocus values SYF at $66.54, suggesting an 8.0% overvaluation. Insiders have sold $847,287 in shares over the past three months. SYF has a GF Score of 89/100, indicating strong performance but with some financial strength concerns.
3 min readGoldman Sachs lowered its price target for Synchrony Financial from $87 to $82 but maintained a buy rating, according to a report published on 10/05/2026. The stock was trading at $71.84, reflecting a 0.09% increase for the day and a 0.36% decrease over the past year.
1 min readSynchrony Financial's CareCredit brand partnered with Vetspire to integrate financing into veterinary software, potentially reshaping payment processes. The deal aligns with Synchrony's embedded finance strategy, but analysts remain cautious about revenue growth and costs. Synchrony's earnings are projected to decline 2.4% annually over the next three years, with revenue expected to reach $16.8B by 2029.
2 min readSynchrony Financial director received a grant of 846 units of common stock, according to an SEC filing. The transaction was valued at $70.97 per share, with the director now holding 6,528 shares.
1 min read
